Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
SKHHY US​

Sonic Healthcare Ltd / ADR Sponsored ADR(SKHHY US)

$13.21-0.090.68%Ext:$13.25+0.040.27%(Market Closed · 20:00:00 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Sonic Healthcare Ltd / ADR Sponsored ADR — Company Profile

Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UU
CEO
James Pacey Newcombe
Headquarters
Sydney, NY, AU
IPO Date
Oct 25, 2010
Employees
49,000
Website
www.sonichealthcare.com

Key Metrics

Price
$12.81
Market Cap
$6.33B
Revenue (TTM)
$10.71B
Net Income (TTM)
$595.00M
EPS (TTM)
1.20
P/E (TTM)
0.00
P/B (TTM)
0.76
Dividend Yield
4.52%
ROE (TTM)
7.13%
ROA (TTM)
3.55%
Operating Margin
9.92%
Beta
0.50

Dividends

Last Dividend
$0.32
Last Yield
0.05%

Summary

Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.

Website
www.sonichealthcare.com
Location
Sydney, NY, AU
Phone61 2 9855 5444
Employees49,000
CEOJames Pacey Newcombe
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateOct 25, 2010

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(7)

Expand
  • F-6 POSPost-effective amendment (depository shares)29 Sep 2017
  • EFFECTNotice of effectiveness28 Aug 2017
  • F-6Registration statement (depository shares)18 Aug 2017
  • F-6EFEffective registration statement (depository shares)10 Dec 2015
  • F-6EFEffective registration statement (depository shares)3 Nov 2014
  • F-6EFEffective registration statement (depository shares)20 Aug 2012
  • F-6EFFORM F-621 Nov 2008

News

  • Sonic Healthcare (OTCMKTS:SKHHY) Shares Gap Down – Here’s Why11 Oct
  • Sonic Healthcare (OTCMKTS:SKHHY) Sets New 12-Month Low – Time to Sell?2 Oct

Key Stats

Trading

Px/Chg 1D$12.81 / +0.39%
Prev Close$13.79
% of 52Wk H79.65%
Avg Volume134.85K
Beta0.50
Mkt Cap6.33B
FD Mkt Cap6.88B

Float

Shrs Out/Float494.08M / 458.20M
Short Float0.00%
Days to Cover1.00
Stock Repurchased$306.16K

Current Valuation

EV11.67B
EV/EBITDA0.00
EV/Sales0.00
P/B0.76
P/S0.00
FCF Yield11.97%
ROE7.13%
ROA3.55%
Current Ratio0.99

Dividend

Cash$0.32
Yield4.52%
Yield (TTM)4.52%

Estimates

P/E0.00
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgDec '22Dec '23Dec '24Dec '25Oct '26
PRICE-BASED RATIOS
Price / Earnings20.036.6814.9215.6952.2410.64
Price / Sales1.351.051.280.902.910.59
Price / Book Value1.061.341.321.010.870.76
Price / Free Cash Flow13.755.2810.4916.3028.348.35
ENTERPRISE VALUE METRICS
Enterprise Value12,087.712,137.112,705.312,045.411,880.411,670.1
Enterprise Value / Sales2.021.301.601.354.771.09
Enterprise Value / EBITDA10.254.337.387.2626.186.10
Enterprise Value / EBIT18.155.7112.4813.6647.9410.98

Financials

Full Financials
Millions AUD5Yr CAGR (%)Jun '22Jun '23Jun '24Jun '25Jun '26
INCOME STATEMENT
Revenue3.6%9,306.57,964.98,934.29,645.410,710.6
Gross Income-3.5%3,412.32,113.92,944.53,188.22,962.0
EBITDA-9.1%2,801.31,721.11,659.31,746.71,912.7
EBIT-15.9%2,125.91,018.2882.0931.41,062.7
Net Income-20.1%1,460.6685.0511.1513.6595.0
EPS (Diluted)-20.6%3.021.451.071.071.20
BALANCE SHEET
Cash & ST Inv-4.3%780.0798.0645.0673.8653.7
Total Assets6.4%13,107.613,561.014,826.516,053.916,781.6
Total Liabilities9.9%5,679.55,639.16,751.37,580.78,287.8
Total Shareholder Equity3.5%7,273.17,736.57,917.68,323.58,339.2
CASH FLOW
Net Operating Cash Flow-11.3%2,225.81,471.01,071.51,296.81,374.7
Cap Ex13%-378.6-497.0-579.5-336.2-617.0
Free Cash Flow-20%1,847.2974.0492.0960.5757.8

Enterprise Value Bridge

Millions AUD23 Oct '26
Price (As of 23 Oct '26)13.25
Basic Shares494.08
Market Cap6,546.6
Diluted Shares494.59
Fully Diluted Shares Outstanding494.59
Fully Diluted Market Cap6,553.3
+Consolidated Debt5,840.1
−In-the-Money Convertible Debt—
+Capital Leases1,710.9
+Operating Leases—
−Cash & Equivalents-653.7
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest154.6
+Pension Liabilities—
Enterprise Value11,887.5

Related companies

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Labcorp Holdings Inc.

LH US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG

RadNet, Inc.

RDNT US

Sotera Health Co

SHC US

Vontier Corp

VNT US

DiaSorin S.p.A.

DSRLF US